This is a demo store. No orders will be fulfilled.
Mycoplasma free
Mycoplasma can persist in cell systems for extended periods without causing turbidity, pH shifts, or microscopically visible particulates, yet it distorts gene expression, alters metabolic pathways, and undermines experimental reproducibility. Beyond cell lines themselves, sera, buffers, enzymes, and other additives can act as covert contamination sources. Mycoplasma-free reagents reduce the risk of introducing contamination through source control and multi-method testing.
I. Impact of Mycoplasma Contamination
- Metabolic interference: Disrupts glucose utilization and amino-acid metabolism, reducing cell viability.
- Skewed gene expression: Abnormal activation of stress genes alters experimental endpoints.
- Protein signaling anomalies: Perturbs phosphorylation states and receptor signaling, confounding functional studies.
- Failure in immunology/pharmacology assays: Introduces uncontrolled variables in immune testing and efficacy/tox studies.
- Long-term culture risk: Often manifests only after many passages, rendering studies non-traceable.
V. Common Issues & Solutions
Issue | Manifestation | Solution |
Abnormal cell status during culture | Slow growth, poor adhesion, metabolic dysregulation | Use mycoplasma-free media/additives; test for mycoplasma regularly |
Unstable transfection efficiency | Divergent expression under identical conditions | Use mycoplasma-free buffers and transfection reagents to reduce interference |
Poor reproducibility in efficacy assays | Inconsistent responses across cell batches | Choose mycoplasma-free reagents to control variables |
Failure after long-term culture | Abnormal phenotypes after many passages; unusable data | Establish preventive systems and use validated mycoplasma-free reagents |
VII. Representative Mycoplasma-Free Products from Aladdin
- UltraBio™ Mycoplasma Removal Agent(M751649)
- Mycoplasma Prevention Reagent (1000X)(M752154)
- Mycoplasma Removal Agent Plus(P751569)
Level / Label | Key Control Criterion | Typical Threshold / Standard* | Common QC Methods | Typical Applications |
Mycoplasma-free | Free of detectable mycoplasma contamination; no interference with cell culture and downstream assays | Mycoplasma tests negative (e.g., culture, fluorescence staining, RT-qPCR) | Bacterial/mycoplasma culture; DNA staining (DAPI/nucleic acid dyes); PCR/RT-qPCR | Cell culture additives; cell therapy research; exosome/transfection workflows and other assays highly sensitive to mycoplasma |
Controlled LPS content to reduce inflammatory responses | Common thresholds ≤0.1–1.0 EU/mL (product-dependent) | LAL assays (gel clot, chromogenic, kinetic) | Plasmid transfection; protein/nanoparticle delivery; animal studies; immunology-related research | |
Free of viable microorganisms | Negative for bacterial/fungal culture | 0.22 μm filtration; sterility testing | Cell culture; upstream prep of injectable solutions; final rinse for equipment | |
Controlled purity; low inhibitors/metal ions/organic residues | Vendor-defined; often paired with nuclease-free claims | Absorbance/fluorescence purity checks; functional validation | DNA/RNA handling; PCR; restriction/ligation | |
Systematic quality system and traceability | Compliant with GMP regulations and registration standards | Quality system audits; batch records; release specifications | Clinical trials/production use |
Note: Thresholds/standards are defined by product category and manufacturer; please refer to the product’s COA/IFU for selection.
Mycoplasma-free reagents are not merely about improving cell-culture reliability; they are essential safeguards against scientific and industrial losses. For studies involving long-term culture, genetic modification, and preclinical validation, selecting mycoplasma-free grade reagents lowers risk, increases data credibility, and lays the groundwork for higher-level translational and compliant research.
View all For Nanopowder Products
首页
400-620-6333